Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 28, 2023

SELL
$0.79 - $1.91 $1,109 - $2,681
-1,404 Reduced 86.88%
212 $0
Q4 2022

Jan 27, 2023

BUY
$1.41 - $2.5 $1,596 - $2,830
1,132 Added 233.88%
1,616 $2,000
Q3 2022

Nov 08, 2022

BUY
$1.66 - $2.79 $803 - $1,350
484 New
484 $1,000
Q2 2022

Aug 10, 2022

SELL
$1.44 - $3.98 $2,191 - $6,057
-1,522 Closed
0 $0
Q1 2022

May 02, 2022

BUY
$2.97 - $5.2 $3,168 - $5,548
1,067 Added 234.51%
1,522 $5,000
Q4 2021

Jan 25, 2022

SELL
$4.99 - $7.46 $9,570 - $14,308
-1,918 Reduced 80.83%
455 $2,000
Q3 2021

Oct 28, 2021

SELL
$7.16 - $9.69 $3,393 - $4,593
-474 Reduced 16.65%
2,373 $17,000
Q2 2021

Jul 26, 2021

BUY
$6.23 - $10.03 $16,584 - $26,699
2,662 Added 1438.92%
2,847 $26,000
Q1 2021

Apr 30, 2021

BUY
$8.81 - $16.96 $1,013 - $1,950
115 Added 164.29%
185 $2,000
Q4 2020

Feb 11, 2021

BUY
$8.5 - $12.85 $595 - $899
70 New
70 $1,000

Others Institutions Holding INO

About INOVIO PHARMACEUTICALS, INC.


  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $1.41B
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.